Ariel Victorio
ASGCT 2024: A Look at Participating Organizations
The American Society of Gene and Cell Therapy (ASGCT) is currently in full swing, bringing together the brightest minds in gene and cell...
top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST
- May 24
Biopharma Bite Sized News May 20th - 24th
New $1.5B ADC manufacturing facility & 9 more updates...👇 🤝 → M&A activity HI-Bio™ & Biogen 🤝 Biogen to acquire HI-Bio for $1.8B...
- May 18
Biopharma Bite Sized News May 13th - 17th
Early-stage antibody company bought for $850M & 9 more updates...👇 Want a list of segmented biopharma companies or access to our online...
- May 10
Biopharma Bite Sized News May 6th - 10th
ASGCT is coming to a close and you can see the breakdown of clinical trial-related abstracts in our post (LI post here). You can see just...
- May 5
🧬 Biopharma Bite Sized News 🍪 April 29th - May 3rd
INGREZZA FDA approval & 9 more major updates... Want a list of segmented biopharma companies or access to our online platform? Get more...
- Apr 26
🧬 Biopharma Bite Sized News 🍪 April 22nd - April 26th
BEQVEZ™ Gene Tx Approved & 9 more major updates...👇 Want a list of segmented biopharma companies or access to our online platform? Get...
- Apr 12
Biopharma approvals, new data, M&A activity, and more - April 12th 2024
Immunotherapy company acquired for >$4B & 10 more updates...👇 Want a list of segmented biopharma companies or access to our online...
- Apr 5
Biopharma approvals, new data, M&A activity, and more - April 5th 2024
$13B acquisition deal + 10 more major updates...👇 Want a list of segmented biopharma companies or access to our online platform? Get...
- Mar 29
Biopharma approvals, new data, M&A activity, and more - March 29th 2024
Oral dual GLP-1/GIP obesity data + 14 more major updates...👇 🎯 → Approvals 🔬 → New data 🤝 → M&A activity Merck 🎯 FDA approved...
- Mar 22
Biopharma approvals, new data, M&A activity, and more - March 22nd 2024
FDA approved gene tx for children w/ early-onset MLD + 13 updates...👇 Optinose 🎯 FDA approved XHANCE, the first and only medication...
- Mar 15
Biopharma Approvals, New Data, M&A activity, and more...
First U.S. NASH/MASH approval + 12 updates...👇 Madrigal Pharmaceuticals 🎯 FDA Approved Rezdiffra™ (resmetirom) for the treatment of...
- Nov 21, 2023
3 Key Insights From FDA’s 1st Review of Gene Editing
BACKGROUND 1st Gene Editing AdCom On 10/31/23 an FDA AdCom met to discuss the safety of VRTX/CRSP’s exa-cel (CTX001) to reduce or...
- Jul 14, 2023
Biopharma Bite Sized News - July 10th to 14th 2023
Cell therapy data, cancer trial safety-induced hold, potential mergers, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ...
- Jul 7, 2023
Biopharma Bite Sized News - July 3rd to 7th 2023
Alzheimer's FDA approval, atopic dermatitis data, new Alzheimer's studies, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor?...
- Jun 30, 2023
Biopharma Bite Sized News - June 26th to 30th 2023
Alzheimer's agitation data, clinical hold lifted, new studies planned, and more.. 💡 Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ...
- Jun 24, 2023
Biopharma News - June 19th to 23rd 2023
Acquisitions, rare disease data, gene therapy approval, and more.. Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a...
- Jun 16, 2023
Biopharma News - June 12th to June 16th 2023
Acquisitions, Alzheimer's data, collaborations, and more.. Are you a CRO, CMO, or Biopharma vendor? BiopharmIQ MarketCompass is a sales...
- Jun 9, 2023
Biopharma Weekly News - June 5th to June 9th 2023
Glioblastoma drug to enter clinic, EHA presentations, clinical hold lifted, and more.. Are you a CRO, CMO, or Biopharma vendor?...
- May 26, 2023
Biopharma Weekly News - May 22nd to May 26th 2023
NASH Data, ASCO abstracts released, and M&A Activity. Read below for a look at major news from biopharma companies.. 🧬 Verastem Oncology...
bottom of page